Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal

Annals of the Rheumatic Diseases

Volumn 78, Issue 7, 2019, Pages 947-956

  Azzouz, Doua ^a   Omarbekova, Aidana ^a   Heguy, Adriana ^a   Schwudke, Dominik ^b   Gisch, Nicolas ^b   Rovin, Brad H ^c   Caricchio, Roberto ^d   Buyon, Jill P ^a   Alekseyenko, Alexander V ^e   Silverman, Gregg J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RESEARCH CENTER BORSTEL   (Germany)

^c OHIO STATE UNIVERSITY   (United States)

^d TEMPLE UNIVERSITY   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

autoantibodies; commensal; gut barrier; microbiome; pathobiont

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DNA ANTIBODY; GLYCAN; RIBOSOME RNA; BACTERIUM ANTIBODY; RNA 16S;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; COHORT ANALYSIS; COMMENSAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DYSBIOSIS; FECES MICROFLORA; FEMALE; HUMAN; IMMUNITY; IMMUNOPATHOGENESIS; INTESTINE FLORA; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MICROBIAL COMMUNITY; NONHUMAN; POLYSACCHARIDE STRUCTURE; PRIORITY JOURNAL; RUMINOCOCCUS; RUMINOCOCCUS GNAVUS; SLEDAI; SPECIES DIVERSITY; SPECIES RICHNESS; BLOOD; CASE CONTROL STUDY; CLOSTRIDIALES; FECES; IMMUNOLOGY; ISOLATION AND PURIFICATION; MICROBIOLOGY; SEVERITY OF ILLNESS INDEX; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIBODIES, BACTERIAL; AUTOANTIBODIES; CASE-CONTROL STUDIES; CLOSTRIDIALES; CROSS-SECTIONAL STUDIES; FECES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; RNA, RIBOSOMAL, 16S; SEVERITY OF ILLNESS INDEX;

EID: 85061918601     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2018-214856     Document Type: Article

References (54)

1. Tsokos GC. Systemic lupus erythematosus. N Engl J Med Overseas Ed 2011;365:2110-21.
2. Hochberg MC. Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis & Rheumatism 1997;40.
3. Borchers AT, Leibushor N, Naguwa SM, et al. Lupus nephritis: A critical review. Autoimmun Rev 2012;12:174-94.
4. Menzel AEO, Heidelberger MJ. Cell protein fractions of bovine and avian tubercle Bacillus strains and of the timothygrass Bacillus. J Biol Chem 1938;124:301-7.
5. Winkenwerder WL, Buell MV, Howard JE. The sensitizing properties of the nucleic acids and their derivatives. Science 1939;90:356.
6. S evag MGL, Smolens J. The isolation of the components of streptococcal nucleoproteins in serologically active form. J Biol Chem 1938;124:425-36.
7. C eppellini R, Polli E, Celada F. A DNA-Reacting factor in serum of a patient with lupus erythematosus Diffusus. Exp Biol Med 1957;96:572-4.
8. Friou GJ. Identification of the nuclear component of the interaction of lupus erythematosus globulin and nuclei. J Immunol 1958;80:476-81.
9. R obbins WC, Holman HR, Deicher H, et al. Complement fixation with cell nuclei and DNA in lupus erythematosus. Exp Biol Med 1957;96:575-9.
10. Goilav B, Putterman C. The role of anti-DNA antibodies in the development of lupus nephritis: A complementary, or alternative, viewpoint? Semin Nephrol 2015;35:439-43.
11. Mannik M, Merrill CE, Stamps LD, et al. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol 2003;30:1495-504.
12. Pedersen HL, Horvei KD, Thiyagarajan D, et al. Murine and human lupus nephritis: pathogenic mechanisms and theoretical strategies for therapy. Semin Nephrol 2015;35:427-38.
13. Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature 2016;535:75-84.
14. A rnolds KL, Lozupone CA. Striking a balance with help from our little friends-how the gut microbiota contributes to immune homeostasis. Yale J Biol Med 2016;89:389-95.
15. R osser EC, Mauri C. A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun 2016;74:85-93.
16. Hevia A, Milani C, López P, et al. Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 2014;5:e01548-14.
17. He Z, Shao T, Li H, et al. Alterations of the gut microbiome in Chinese patients with systemic lupus erythematosus. Gut Pathog 2016;8.
18. L uo XM, Edwards MR, Mu Q, et al. Gut microbiota in human systemic lupus erythematosus and a mouse model of lupus. Appl Environ Microbiol 2018;84:4.
19. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005;353:2550-8.
20. C ole JR, Wang Q, Fish JA, et al. Ribosomal database project: data and tools for high throughput rRNA analysis. Nucleic Acids Res 2014;42:D633-D642.
21. Wang Q, Garrity GM, Tiedje JM, et al. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 2007;73:5261-7.
22. S chloissnig S, Arumugam M, Sunagawa S, et al. Genomic variation landscape of the human gut microbiome. Nature 2013;493:45-50.
23. L iu C, Finegold SM, Song Y, et al. Reclassification of Clostridium coccoides, Ruminococcus hansenii, Ruminococcus hydrogenotrophicus, Ruminococcus luti, Ruminococcus productus and Ruminococcus schinkii as Blautia coccoides gen. nov., comb. nov., Blautia hansenii comb. nov., Blautia hydrogenotrophica comb. nov., Blautia luti comb. nov., Blautia producta comb. nov., Blautia schinkii comb. nov. and description of Blautia wexlerae sp. nov., isolated from human faeces. Int J Syst Evol Microbiol 2008;58:1896-902.
24. C allahan BJ, McMurdie PJ, Rosen MJ, et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat Methods 2016;13:581-3.
25. Gonzalez ME, Schaffer JV, Orlow SJ, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol 2016;75:481-93.
26. Gauffin Cano P, Santacruz A, Moya Á, et al. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One 2012;7:e41079.
27. Gisbert JP, Bermejo F, Pérez-Calle JL, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009;15:1190-8.
28. R ainone V, Schneider L, Saulle I, et al. Upregulation of inflammasome activity and increased gut permeability are associated with obesity in children and adolescents. Int J Obes 2016;40:1026-33.
29. Fotis L, Shaikh N, Baszis KW, et al. Serologic evidence of Gut-driven systemic inflammation in juvenile idiopathic arthritis. J Rheumatol 2017;44:1624-31.
30. Davis P, Cumming RH, Verrier-Jones J. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus. Clin Exp Immunol 1977;28:226-32.
31. L efkowith JB, Kiehl M, Rubenstein J, et al. Heterogeneity and clinical significance of glomerular-binding antibodies in systemic lupus erythematosus. J Clin Invest 1996;98:1373-80.
32. Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002;117:316-24.
33. Hess N, Waldow F, Kohler TP, et al. Lipoteichoic acid deficiency permits normal growth but impairs virulence of Streptococcus pneumoniae. Nat Commun 2017;8;(1).
34. Gisch N, Auger JP, Thomsen S, et al. Structural analysis and immunostimulatory potency of lipoteichoic acids isolated from three Streptococcus suis serotype 2 strains. J Biol Chem 2018;293:12011-25.
35. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004;15:241-50.
36. Yurkovetskiy L, Burrows M, Khan AA, et al. Gender bias in autoimmunity is influenced by microbiota. Immunity 2013;39:400-12.
37. N elson KE, Weinstock GM, Human Microbiome Jumpstart Reference Strains Consortium, et al. A catalog of reference genomes from the human microbiome. Science 2010;328:994-9.
38. Tsao JT, Hsieh SC, Chiang BL, et al. Altered IL-10 and TNF-β?production in peripheral blood mononuclear cells of systemic lupus erythematosus patients after Toll-like receptor 2, 4, or 9 activation. Clin Exp Med 2012;12:153-8.
39. A lmaani S, Meara A, Rovin BH. Update on Lupus nephritis. Clin J Am Soc Nephrol 2017;12:825-35.
40. Flint HJ, Bayer EA, Rincon MT, et al. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Micro 2008;6:121-31.
41. C rost EH, Tailford LE, Le Gall G, et al. Utilisation of mucin glycans by the human gut symbiont Ruminococcus gnavus is strain-dependent. PLoS One 2013;8:e76341.
42. Dabard J, Bridonneau C, Phillipe C, et al. Ruminococcin A, a new lantibiotic produced by a Ruminococcus gnavus strain isolated from human feces. Appl Environ Microbiol 2001;67:4111-8.
43. E un CS, Mishima Y, Wohlgemuth S, et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota Consortium in gnotobiotic interleukin-10-/-mice. Infect Immun 2014;82:2239-46.
44. Hoffmann TW, Pham HP, Bridonneau C, et al. Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. Isme J 2016;10:460-77.
45. Breban M, Tap J, Leboime A, et al. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis. Ann Rheum Dis 2017;76:1614-22.
46. Hall AB, Yassour M, Sauk J, et al. A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med 2017;9.
47. Gul'neva M, Shilkina NP. Intestinal microbial biocenosis in patients with systemic lupus erythematosus treated with prednisolone]. Klin Med 2009;87:42-5.
48. Maier L, Pruteanu M, Kuhn M, et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:623-8.
49. Kovacs-Simon A, Titball RW, Michell SL. Lipoproteins of bacterial pathogens. Infect Immun 2011;79:548-61.
50. Van Praet JT, Donovan E, Vanassche I, et al. Commensal microbiota influence systemic autoimmune responses. Embo J 2015;34:466-74.
51. Manfredo Vieira S, Hiltensperger M, Kumar V, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science 2018;359:1156-61.
52. A rbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33.
53. A pperloo-Renkema HZ, Bootsma H, Mulder BI, et al. Host-microflora interaction in systemic lupus erythematosus (SLE): colonization resistance of the indigenous bacteria of the intestinal tract. Epidemiol Infect 1994;112:367-73.
54. Fasano A. Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 2012;42:71-8.